期刊文献+

GSTA1基因C-69T多态性与糖尿病视网膜病变的相关性研究 被引量:1

Association Analysis of the Polymorphism of GSTA1 Gene C-69T and Diabetic Retinopathy
原文传递
导出
摘要 糖尿病视网膜病变是糖尿病最常见的微血管病变之一,是工作年龄成人致盲的主要原因。氧化应激是活性氧生成和清除不平衡的结果,在糖尿病视网膜病变的发生中起重要作用。GSTA1是重要的氧化应激相关的谷胱甘肽硫转移酶之一,目前暂没有其多态性与糖尿病视网膜病变发病之间的研究。本实验以546例2型糖尿病样本为研究对象,根据直接眼底镜的结果把病人分成糖尿病视网膜病变组和有糖尿病但没有视网膜病变组。采用构象差异凝胶电泳方法检测GSTA1基因C-69T多态性。GSTA1基因C-69T多态性的CC、CT和TT种基因型在DR组的频率分别为79.8%、17.7%和2.5%,在NDR组的频率分别为77.8%、20.6%和1.6%,两组比较差异无统计学意义(x^2=1.254,p=0.561)。本实验结果表明,GSTA1基因C-69T多态性与中国江西汉族糖尿病视网膜病变的发病没有关联。 Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes mellitus (DM) and the leading cause of acquired blindness in adults of working age. Oxidative stress is the result of disequilibrium between production and scavenging of reactive oxygen spices (ROS). It plays an important role in the development of diabetic retinopathy. GSTA1 is one enzyme of glutathione S-transferases, and there are no studys between its polymorphisms and diabetic retinopathy. Based on the results of direct funduscopy detection, 546 cases of 2 diabetes mellitus patients were divided into 2 groups: diabetic retinopathy (DR) group and non-diabetic retinopathy (NDR) group. GSTA 1 C-69T polymorphism were genotyped by PCR conformation difference gel electrophoresis (PCR-CDGE). The frequencies ofgenotype CC, CT and TT at GSTAI C-69T polymorphism in DR group and NDR group were 79.8%, 17.7%, 2.5% and 77.8%, 20.6%, 1.6%, respectively. There was no significant difference in genotype between DR group and NDR group (χ2=1.254, p=0.561). The result of the research showed that GSTA1 C-69T polymorphism might be not associated with diabetic retinopathy in Jiangxi Han nationality patients.
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2017年第8期3304-3308,共5页 Genomics and Applied Biology
基金 江西省教育厅科学技术研究基金项目(No.:GJJ13165)资助
关键词 糖尿病视网膜病变 GSTA1基因 基因多态性 Diabetic retinopathy, GSTA1, Gene polymorphism
  • 相关文献

参考文献3

二级参考文献28

  • 1黄静,徐进,左翼,徐伟东,吴自荣.重组人胰高血糖素样肽-1的表达及生物学活性[J].中国生物工程杂志,2006,26(1):50-55. 被引量:7
  • 2Coles BF,Morel F,Rauch C,et al.Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression.Pharmacogenetics,2001,11:663--669.
  • 3Sweeney C,Ambrosone CB,Joseph L,et al.Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment.Int J Cancer,2003,103:810-814.
  • 4Coles B,Nowell SA,MacLeod SL,et al.The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP,and the effect of a polymorphism in hGSTA1 on colorectal cancer risk.Mutat Res,2001,482:3-10.
  • 5Ahn J,Gammon MD,Santella RM,et al.Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk.Carcinogenesis,2006,7:1876-1882.
  • 6Khrunin AV,Moisseev A,Gorbunova V,et al.Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients.Pharmacogenomics J,2010,10:54-61.
  • 7Rossi D,Rasi S,Franceschetti S,et al.Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.Leukemia,2009,23:1118-1126.
  • 8Mannervik B,Awasthi YC,Board PG,et al.Nomenclature for human glutathione transferases.Biochem J,1992,282:305-306.
  • 9Kweekel DM,Koopman M,Antonini NF,et al.GSTP1 Ilel05Valpolymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan:a study of the Dutch Colorectal Cancer Group.Br J Cancer,2008,99:1316-1321.
  • 10Cho HJ,Eom HS,Kim HJ,et al.Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma.Cancer Genet Cytogenet,2010,198:40-46.

共引文献15

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部